Podcasts Health & Fitness Medicine NEJM Interviews NEJM Interview: Dr. Ameet Sarpatwari on a legal case that could affect market entry of generic and biosimilar drugs.

NEJM Interview: Dr. Ameet Sarpatwari on a legal case that could affect market entry of generic and biosimilar drugs.

Published: Feb. 8, 2023, 3:01 p.m.

b'Dr. Ameet Sarpatwari is an assistant professor of medicine at Harvard Medical School and the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women\\u2019s Hospital and Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.S. Tu and A. Sarpatwari. A \\u201cMethod of Use\\u201d to Prevent Generic and Biosimilar Market Entry. N Engl J Med 2023;388:483-485.'